Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib + Paclitaxel in 1L HER2+ MBC
NCT00356811Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in breast cancer, sponsored by GSK. Primary endpoint: Overall Response Rate. Started May 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00356811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356811.